According to our new research study on “Infectious Disease Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Technology, Testing Type, Disease Indication, and End User,” the market is expected to grow from US$ 23,890.61 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028.

The growth of the global Infectious Disease Diagnostic Market is majorly driven by an increase in the prevalence of infectious diseases, including hepatitis, influenza, COVID-19, and human immunodeficiency virus (HIV); a rise in demand for point-of-care diagnostic tests; a surge in funding from private & government organizations for diagnostic service centers; and advancements in technologies in the field of infectious disease diagnostics. However, the high cost associated with diagnostic instruments and the lack of skilled technicians in the global market is hampering the market growth.

Infectious diseases are caused by infectious agents, such as viruses, bacteria, parasites, fungi, and toxic products. HIV is a major global public health issue. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), ~ 37.7 million people were HIV positive in 2020, out of which 1.7 million were children aged below 14 years and 36 million were adults.

Get PDF Sample Copy @ https://www.theinsightpartners.com/sample/TIPHE100001430/

The COVID-19 outbreak is straining healthcare systems globally, increasing the need to develop diagnostic devices and service centers. Moreover, hospital-acquired or healthcare-associated infections (HAIs) have high morbidity and mortality rate. The Centers for Disease Control (CDC) reported that HAIs account for ~1.7 million infection cases and 99,000 deaths every year in American hospitals.

Diagnostics play an essential role in determining the direction of any medical treatment of infectious diseases. Therefore, the rising prevalence of infectious diseases across the globe propels the growth of the infectious disease diagnostics market.

The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company's growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.

F.Hoffmann-La Roche, Ltd.; Danaher Corporation; BD; bioMérieux SA; AccuBioTech Co., Ltd.; Bio-Rad Laboratories, Inc.; ACON Laboratories, Inc.; Abbott; Trinity Biotech; and Cardinal Health, Inc. are among the leading companies operating in the infectious disease diagnostics market. Product launches, product approvals, mergers and acquisitions, and market initiatives are a few growth strategies adopted by the companies. For instance, in March 2020, F.Hoffmann-La Roche Ltd. 

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876